Imagene AI

Executive Summary

Imagene AI is a privately held pioneer in multimodal foundation models for precision medicine, based in New York. The company leverages advanced AI to integrate diverse biomedical data, aiming to accelerate translational research, improve clinical trial design, and personalize patient journeys. While specific funding, valuation, and pipeline details remain undisclosed, its focus on multimodal AI in diagnostics positions it within a rapidly growing market. The company's success hinges on validating its models in real-world settings and securing partnerships or funding to advance its platform. As an early-stage entity, its conviction is tempered by lack of public traction.

Upcoming Catalysts (preview)

• Q3 2026Pharmaceutical partnership for trial enrichment40% success
• Q4 2026Peer-reviewed publication of validation study60% success
• Q2 2026Series A funding round closure50% success